发明名称 Detection, prevention, and treatment of anthrax and other infectious diseases
摘要 Compositions and methods for the detection, prevention, or treatment of anthrax or other infectious diseases. In one aspect, the present invention provides methods for immunizing humans or animals against Bacillus anthracis or other capsulated pathogens. The methods include administering a capsular polypeptide of a pathogen of interest and a CD40 agonist to a human or animal. The capsular polypeptide or the CD40 agonist is administered in such an amount or frequency that an immunoprotective response can be elicited in the human or animal against the pathogen of interest. In another aspect, the present invention provides methods of using passive immunization with anti-capsular polypeptide antibodies to prevent or treat infections caused by Bacillus anthracis or other pathogens. In yet another aspect, the present invention provides methods useful for diagnosis of anthrax by detection of capsular polypeptide in serum or other biological samples.
申请公布号 US9435804(B2) 申请公布日期 2016.09.06
申请号 US201313967259 申请日期 2013.08.14
申请人 Board of Regents of the Nevada System of Higher Education, on behalf of the University of Nevada, Reno;Regents of the University of Minnesota;STC UNM 发明人 Kozel Thomas;Murphy William;Brandt Suzanne;Blazar Bruce R;Lovchik Julie A;Thorkildson Peter;Percival Ann;Lyons C. Rick
分类号 G01N33/53;A61K39/07;A01K39/02;G01N33/569 主分类号 G01N33/53
代理机构 Klarquist Sparkman, LLP 代理人 Klarquist Sparkman, LLP
主权项 1. A method of diagnosing infection by a PGA producing pathogen in a subject from a vertebrate species, comprising: assaying soluble PGA in a biological sample obtained from the subject using an anti-PGA antibody, the assay generating a detectable signal if the level of soluble PGA in the sample exceeds a predetermined amount, the predetermined amount is 140 pg/ml.
地址 Reno NV US